UnitedHealth Group Incorporated remains a strong long-term buy despite recent headwinds. Click here to read an analysis of ...

Amwell's Q1 2025 results reveal strong revenue growth, but DHA contract renewal is crucial. Learn why caution is advised ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class ...

LevelJump Healthcare (TSXV:JUMP) announced its financial results for 2024, offering up some robust revenue growth and decent ...